Canandaigua National Trust of Florida’s Bristol-Myers Squibb BMY Stock Holding History

Canandaigua National Trust of Florida’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,601	Closed	-$220K	–	123
2025 Q1	$220K	Buy	+3,601	New	+$210K	0.19%	98

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canandaigua National Trust of Florida's BMY Position: Q2 2025 in Review

Canandaigua National Trust of Florida sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,601 shares — an estimated $220K sold.

Canandaigua National Trust of Florida first reported a position in BMY in Q1 2025 and held it in 1 quarter. The position peaked at $220K in Q1 2025. 2,295 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Canandaigua National Trust of Florida reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Canandaigua National Trust of Florida sold 3,601 Bristol-Myers Squibb shares in Q2 2025, an estimated $220K.
Canandaigua National Trust of Florida first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 1 quarter.
Canandaigua National Trust of Florida's Bristol-Myers Squibb position peaked at $220K in Q1 2025.
2,295 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Canandaigua National Trust of Florida's 13F filing for Q2 2025, filed 8 Jul 2025.